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Abstract
Background: Fibrocytes are bone-marrow derived cells, expressing both haematopoietic and stromal cell markers, which
contribute to tissue repair as well as pathological fibrosis. The differentiation of fibrocytes remains poorly characterised and
this has limited understanding of their biology and function. In particular two methods are used to generate fibrocytes in
vitro that differ fundamentally by the presence or absence of serum.
Methodology/Principal Findings: We show here that fibrocytes grown in the absence of serum (SF) differentiate more
efficiently from peripheral blood mononuclear cells than CD14
+ monocytes, and respond to serum by losing their spindle-
shaped fibrocyte morphology. Although fibrocytes generated in the presence of serum (SC) express the same range of
markers, they differentiate more efficiently from CD14
+ monocytes and do not change their morphology in response to
serum. Transcriptional analysis revealed that both types of fibrocyte are distinct from each other, fibroblasts and additional
monocyte-derived progeny. The gene pathways that differ significantly between SF and SC fibrocytes include those
involved in cell migration, immune responses and response to wounding.
Conclusions/Significance: These data show that SF and SC fibrocytes are distinct but related cell types, and suggest that
they will play different roles during tissue repair and fibrosis where changes in serum proteins may occur.
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Introduction
Fibrocytes are bone-marrow derived cells that are recruited into
sites of tissue injury, most likely as precursor cells, and differentiate
into spindle-shaped cells that contribute to repair and angiogen-
esis, with the potential to induce pathological fibrosis [1,2]. They
are characterised by the expression of both stromal and
haematopoietic markers. In particular they produce extracellular
matrix molecules including collagen types I and III and
fibronectin, while also expressing CD45 and CD34, and can be
distinguished from monocytes, macrophages and fibroblasts
through a combination of markers [3].
It has been suggested that fibrocytes can act as antigen-
presenting cells, responding to TLR ligands [4] and inducing
significant T cell proliferation due to the expression of MHC class
II and CD86 [5]. However, the primary role of fibrocytes appears
to be very similar to local tissue fibroblasts, in providing
extracellular matrix deposition during tissue repair, and both cell
populations can be isolated from wound chambers [6]. Impor-
tantly there is also strong evidence that fibrocytes contribute to
pathological fibrosis in a number of tissues, particularly the lung
and kidney [7,8]. Spindle-shaped cells accumulate during
bleomycin-induced pulmonary fibrosis where they express both
CD45 and collagen I. Fibrosis can be enhanced in this model by
intravenous injection of in vitro-generated fibrocytes, with the cells
recruited to the lungs via their expression of CXCR4 [9]. By
contrast, for FITC-induced pulmonary fibrosis, fibrocytes use the
CCR2-CCL12 axis for their recruitment [10]. Once fibrocytes
have been recruited and/or differentiated in the repairing/fibrotic
tissues they may further differentiate towards a myofibroblast
phenotype with the expression of a-smooth muscle actin [9,11];
the precise contribution of fibrocytes to the myofibroblast
population may vary depending on the tissue and context.
Recently fibrocytes have also been shown to promote healing
during colonic inflammation [12].
Fibrocytes can differentiate in vitro from either peripheral blood
mononuclear cells or purified CD14
+ monocytes. Thus fibrocytes
represent one of a number of cell types that can differentiate from
monocytes, including macrophages, osteoclasts and dendritic cells
[13]. In the presence of serum, fibrocytes require up to 2 weeks to
differentiate [6], whereas in the absence of serum this process is
accelerated, with cells appearing in culture after only a few days
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9730[14], Interestingly the differentiation of fibrocytes is inhibited by
serum amyloid P (SAP), a major constituent of serum [14], and
bleomycin-induced pulmonary fibrosis can be inhibited by SAP
[15]. A number of other molecules can influence the differenti-
ation of fibrocytes in vitro, and presumably in vivo. TGFb1, IL-4 and
IL-13 all promote fibrocyte differentiation, with IL-12 and IFNc
being inhibitory [16,17]. It is currently assumed that fibrocytes
that differentiate in the presence or absence of serum reflect the
same cell type, differing only in their kinetics of generation. In this
study we have addressed this issue by studying the phenotype,
growth and differentiation characteristics, response to serum and
transcriptome of fibrocytes generated under both serum-free (SF)
and serum-containing (SC) conditions. Our data show that these
two types of fibrocytes, while closely related, are nevertheless
distinct, suggesting that they may play different roles during the
response to wounding.
Results
Fibrocytes were generated by culture of PBMC or CD14
+
monocytes (purity .98%) in either SF or SC medium (20% heat-
inactivated FCS), as previously described in the literature [6,14].
For both culture conditions, after a few days elongated cells with a
fibrocyte morphology began to appear (Fig. 1A,B). In SF
conditions the fibrocytes appeared after only 4 days and reached
a peak at 6 days, whereas in the presence of serum differentiation
required a longer period of culture and did not peak until day 12,
as previously described [6,14]. Interestingly, more SF than SC
Figure 1. Differential generation of fibrocytes in serum-free or serum-containing conditions, from PBMC and CD14
+ monocytes.
Fibrocytes were generated from PBMC (filled circles) or purified CD14
+ monocytes (open circles) in either serum-free (SF) or serum-containing (SC;
20% HIFCS). The number of fibrocytes is shown during an 18-day culture period (A,B; mean 6 sd of triplicate culture wells). Error bars are only shown
in one direction for clarity. Bar represents 50 mm. Fibrocytes and macrophages (MØ) were generated from a number of different normal healthy
volunteers (minimum of n=6) and the number of cells per well counted at day 11 of culture (C). *=p,0.05; ***=p,0.001; Mann-Whitney test.
doi:10.1371/journal.pone.0009730.g001
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than SF fibrocytes from purified CD14
+ monocytes (Fig. 1C).
There was no significant difference in the ability of each cell
population to generate macrophages. The loss of SC fibrocyte
numbers at d5–7 did not occur in all experiments (Fig. S1), and
appears to be related to the washing step performed at d4.
SF and SC fibrocytes both expressed haematopoietic markers
and stromal markers. The stromal markers fibronectin, collagen I
and vimentin were expressed by both SF and SC fibrocytes, as well
as fibroblasts, but were not expressed by macrophages generated
in parallel from the same preparations, except for vimentin which
showed a similar degree of expression on macrophages (Fig. 2A).
There was also a lower level of expression for collagen III on
fibrocytes. The haematopoietic markers CD45 and CD68 were
expressed by both types of fibrocyte, as well as macrophages, but
were virtually negative on fibroblasts. The few cells that appear to
express CD45 are also present with the isotype control. CD13 and
CD3 were positive and negative for all cell populations,
respectively (Fig. 2B).
The differences in the generation of fibrocytes under SF and SC
conditions (Fig. 1) suggested that these cells may respond
differently to the presence of serum within the culture medium.
To investigate the effects of serum on SF fibrocytes we initiated the
culture of PBMC in serum-free conditions, and then at either day
4, 8, 11 or 14 replaced the SF medium for SC medium. The
number of cells with fibrocyte morphology was assessed until day
18 of the culture. Irrespective of the day at which the serum-
containing medium was added there was a loss of cells with a
fibrocyte morphology, within 120 min, which persisted for the
length of the culture (Fig. 3A,B). Although there was a large,
statistically significant, effect of the addition of serum (Fig. 3D),
when the reciprocal experiment was performed there was little
effect of the change of medium on SC fibrocytes (Fig. 3C,D).
Identical results were obtained when cultures were generated from
CD14
+ monocytes (Fig. S1). The effect was found for a variety of
different sera, and was not due to the use of RPMI or DMEM
culture media (Fig. S2); plasma can also be substituted for serum
(data not shown). The expression of both stromal and haemato-
poietic markers was maintained when SF fibrocytes were switched
into SC conditions (Fig. S3), suggesting that the cells were still
fibrocytes but had lost their distinct morphology.
The above data suggested that there were both shared and
distinct features of SF and SC fibrocytes. We wished to look more
closely at the relationship between these two types of fibrocyte, as
well as other monocyte-derived progeny and fibroblasts. cDNA
microarrays were performed for each cell population from three
different individual donors, each in technical triplicate. The data
from SF and SC fibrocytes, CD14
+ monocytes, immature and
mature dendritic cells (DC), osteoclasts, macrophages and
fibroblasts were analysed using significance analysis of microarrays
(SAM) with a 0.1% false discovery rate, and the resultant gene lists
were used for principal component analysis (PCA). When all cell
populations were included the SAM identified 24452 significantly
different genes (Table S1), and the PCA showed that the
fibroblasts formed a distinct cluster away from the other
populations (Fig. 4A). Removal of the fibroblasts from the analysis
produced a SAM list of 21526 genes (Table S2) and the PCA
began to show a distinction between the monocyte-derived
progeny (Fig. 4B). In particular the macrophages, SF fibrocytes,
monocytes and mature DC formed distinct clusters. Reducing the
analysis to just the macrophages, SF and SC fibrocytes generated a
list of 3543 genes (Table S3), and the PCA clearly showed three
distinct clusters (Fig. 4C). When just the two types of fibrocyte
were analysed the SAM list contained 5144 genes (Table S4), and
the two cell populations were clearly separated along the first
principal component (Fig. 4D). There was always a group of 3 SF
fibrocytes that clustered away from the other populations, but still
closest to the other SF fibrocytes, and these were triplicates from a
single donor. The SAM gene list from the paired 2-way fibrocyte
analysis was used to generate a dendrogram, clustered for both
type samples and genes. This showed multiple gene clusters that
were responsible for the separation of the two types of fibrocyte,
with both up and down-regulated genes for each type of fibrocyte.
A gene pathway analysis (DAVID) was performed on those genes
from the SAM list between the two types of fibrocyte (Table 1;
Benjamini p,0.001, .2-fold enrichment). The most significant
gene pathways that distinguish SF and SC fibrocytes include the
immune and inflammatory response, chemotaxis, RNA processing
and lipid metabolism pathways. Genes common to many of the
pathways that were up-regulated in SC fibrocytes included TLR4,
IL-1b, and the chemokines CCL2, 3, 7 and 22, and the C5a
complement receptor. A complete list of the significant DAVID
pathways is also provided (Table S5).
Discussion
It is now well established that fibrocytes are bone-marrow
derived cells, expressing both haematopoietic and stromal cell
markers, that play key roles in tissue repair, angiogenesis and
pathological fibrosis [1,2,8]. However, two methods have been
described in the literature for the in vitro generation of fibrocytes
from peripheral blood mononuclear cells; the major difference in
culture medium is the presence [6] or absence [14] of serum.
Given the changes in serum protein concentrations that occur
during tissue repair, inflammation and its resolution, understand-
ing the effects of serum on the differentiation and function of
fibrocytes is of critical importance. In this study we have compared
the growth, phenotype, transcriptome and response to serum of
fibrocytes generated under SF and SC conditions. Our data
indicate that although both cells can be described as fibrocytes
they have distinct properties that may relate to their proposed roles
in vivo.
The current definition of a fibrocyte is a spindle-shaped cell that
expresses both haematopoietic and stromal cell markers. Consis-
tent with published literature [6,14] both SF and SC fibrocytes
expressed CD45 and other haematopoietic markers, as well as
fibronectin, collagen I and III and vimentin, both with an
elongated spindle-shaped morphology. Therefore, it is clear that
the cells differentiated under both SF and SC conditions can be
classified as fibrocytes.
Fibrocytes can differentiate in vitro directly from CD14
+
monocytes as well as from a more heterogeneous PBMC
population [6,14,16]. We observed a difference in the ability of
SF and SC fibrocytes to differentiate from PBMC and CD14
+
peripheral blood cells, with more efficient generation of SF from
PBMC, and SC from CD14
+ cells. This raises the possibility that
these cells represent two distinct types of fibrocyte that arise from
different precursor cells, present at different frequencies within the
PBMC and CD14
+ cell populations, or differentially affected by
the presence of other leukocyte populations. It was previously
suggested that T cells enhance the differentiation of SC fibrocytes
from CD14
+ monocytes [16,18], although paradoxically our data
showed a more efficient generation of these fibrocytes from
purified CD14
+ cells than PBMC. We also found a number of
other differences between SF and SC fibrocytes. These included
the more rapid differentiation of SF fibrocyte in culture, as
previously commented on by Pilling et al [14], and distinct
transcriptome profiles. Regardless of the origins of SF and SC
Fibrocyte Differentiation
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9730Figure 2. Both serum-free and serum-containing fibrocytes express both haematopoietic and stromal cell markers. Fibrocytes were
generated from PBMC under serum-free (SF) and serum-containing (SC) culture conditions, as well as macrophages. Fibroblast cell lines were
included as a positive control for stromal cell markers. Immunostaining is shown in red for the stromal markers fibronectin, collagens I and III and
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presence and absence of serum is not identical. Our analysis of the
microarray data assumed that any differences observed were due
to the fibrocytes and not contaminating monocyte, or monocyte-
derived populations. While there is clearly the potential for some
contamination we do not believe this to be significant. Although
the numbers of fibrocytes in our cultures may appear low
compared to the input number, these counts were determined
by morphology. The expression of fibronectin (Fig. 2) clearly
shows that the percentage of fibrocytes in the cultures was actually
very high, and that many cells that would not have been counted
as fibrocytes by morphology nonetheless expressed both stromal
and haematopoietic markers. In addition, our microarray analysis
included both monocytes and monocyte-derived progeny (DC,
macrophages and osteoclasts), and yet the fibrocyte populations
formed distinct clusters upon analysis of the microarray data.
Monocytes have the potential to differentiate into a number of
cell lineages, including macrophages, dendritic cells, fibrocytes,
osteoclasts and adipocytes. SAM analysis of the two types of
fibrocyte with a number of other monocyte-derived progeny, as
well as fibroblasts, revealed that SC fibrocytes were most related
to macrophages and osteoclasts, with SF fibrocytes forming a
more distinct cluster, away from other monocyte-derived
progeny, but also from fibroblasts. The gene pathways identified
by DAVID suggest that the SF and SC fibrocytes differ in a
number of key areas including response to wounding, inflamma-
tory response and cell migration. Interestingly, a high number of
gene pathways associated with lipid metabolism were significantly
enhanced in SC fibrocytes. This is consistent with the ability
of SC fibrocytes to differentiate to adipocytes [19]. It remains to
be determined whether SF fibrocytes retain this degree of
multipotency.
Until recently the major cell population thought to be
responsible for matrix deposition during tissue repair and fibrosis
was the fibroblast. These stromal tissue-resident cells are clearly
important players in these processes, with evidence for both their
proliferation and differentiation towards myofibroblasts [20].
However, recent evidence has implicated fibrocytes in these
processes [1,2]. During the repair of tissues the concentration of
serum-derived proteins will initially be very high, due to the loss of
tissue integrity and increased endothelial permeability, and would
result in the differentiation of SC fibrocytes. However, as repair
proceeds concentrations will fall, favouring the differentiation of
serum-free fibrocytes. Although at any one moment in time all
infiltrating monocytes would be exposed to the same concentration
of serum-derived proteins, this concentration would change during
the time-course of the response, and therefore so would the
potential to differentiate into either SF or SC fibrocytes. It is
possible that the overall serum concentration may control
differentiation, or that specific factors present in serum, including
serum amyloid P, may drive this process. Although many features
were shared between SF and SC fibrocytes (morphology,
expression of matrix proteins), the clear transcriptional differences
that we observed suggest that they may fulfil distinct roles within
the tissue, and that due to the effects of serum on their
differentiation this would happen at different times during tissue
repair and fibrosis. For example, the differentiation of fibrocytes
from monocyte precursors that are constantly recruited to sites of
chronic inflammation may favour SF fibrocytes due to the
relatively low levels of serum protein that will be present, as
compared to acute tissue injury. Interestingly, even when SF
fibrocytes had differentiated, we observed a strong effect of serum
resulting in the rounding up of these cells. It is possible that this
process might allow these fibrocytes to migrate away from the
tissue site. We have not been able to identify the component in
serum responsible for this change of phenotype, although it does
not appear to be SAP (data not shown). This is clearly an
important issue for future research, as changes in fibrocyte
numbers may either prevent further pathological fibrosis or even
contribute to its resolution.
Materials and Methods
Ethics statement
This study was approved by the Black Country Research Ethics
Committee (07/Q2702/54) and following informed written
consent, all samples were collected and stored according to the
Human Tissue Act (U.K.).
Isolation of PBMC and CD14
+ monocytes
Peripheral blood was taken by venepuncture from healthy
volunteer donors into preservative-free heparin. Peripheral blood
mononuclear cells (PBMC) were isolated by density-gradient
centrifugation using Ficoll-Paque (GE Healthcare Biosciences,
Amersham, UK) according to the manufacturer’s instructions, and
were washed five times with RPMI 1640 to ensure removal of
platelets. CD14
+ monocytes were isolated by positive selection
using magnetic beads (Miltenyi Biotec, Bisley, UK). PBMC were
re-suspended at 80 ml per 10
7cells in PBS, 0.5% bovine serum
albumin (Sigma-Aldrich, Irvine, U.K.), 2 mM EDTA, with 20 ml
of anti-CD14
+ beads (Miltenyi Biotec) and incubated at 4uC for
15 min. Cells were washed twice by centrifugation before isolation
of the bead-bound cells on a magnetised column. A sample of cells
were labelled with a FITC anti-CD14 antibody that binds to a
distinct (non-competing) epitope from the antibody used for cell
isolation (Immunotools, Friesoythe, Germany) and analysed by
flow cytometry. Cells were always .95% and routinely .98%
CD14
+ (data not shown).
Generation of fibrocytes
Fibrocytes were generated by cell culture using two different
growth media [6,14]. Serum-free fibrocyte medium consisted of
RPMI 1640 (Sigma-Aldrich), supplemented with 1% GPS
(1.64 mM L-glutamine, 40 U/ml benzylpenicillin, 0.4 mg/ml
streptomycin; Sigma-Aldrich), 1% Hepes buffer (Sigma-Al-
drich), 1% liquid media supplement (ITS+3)(Sigma-Aldrich)
1% non-essential amino acids (Sigma-Aldrich) and 1% sodium
pyruvate (Sigma-Aldrich). Serum-containing fibrocyte medium
consisted of Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma-Aldrich) supplemented with 1% GPS and 20% heat-
inactivated (HI; 56uC for 1 h) fetal calf serum (FCS; Biosera,
Ringmer, U.K.). All cell cultures were performed at 37uC, 5%
CO2 in a humidified incubator. PBMC (10
6/ml) or CD14
+ cells
(2610
5/ml) were resuspended in either SF or SC medium and
cultured in either 8 well glass chamber slides or 24 well plastic
plates for the number of days indicated. The starting cell
concentrations for each population were those that generated
the maximum yield of fibrocytes in preliminary experiments,
their rabbit IgG control, with vimentin and its mouse IgG1 control in green (A). Immunostaining is shown in red for the haematopoietic markers CD45,
CD13, CD3 and CD68, and their isotype controls mouse IgG2b and IgG1 (B). Nuclear staining is shown in blue. Bar represents 50 mm. Data are
representative of at least two separate experiments.
doi:10.1371/journal.pone.0009730.g002
Fibrocyte Differentiation
PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9730and also ensured a similar number of monocytes in each. At day
4 the non-adherent cells were washed out and every 7 days half
the medium was removed and replaced with fresh medium. The
number of fibrocytes was determined by counting triplicate wells
with three fields of view per well. Human synovial fibroblast cell
lines were generated as previously described [21] and cultured
in RPMI 1640, 1% GPS, 10% FCS, 1% non-essential amino
acids and 1% ITS+3. Fibroblasts were expanded by trypsin
digestion and reseeding into tissue culture flasks of twice the
s u r f a c ea r e a .C e l l sw e r eh a r v e s t e df o ra n a l y s i so n c et h e yh a d
Figure 3. Addition of serum to serum-free generated fibrocytes results in a loss of fibrocyte morphology. Fibrocytes generated from
PBMC under serum-free (SF) culture conditions were cultured in the presence of serum-containing (SC) culture medium, and video recordings taken
for a period of 150 min. Still photographs are shown after each 30 min period (A), with arrows indicating individual cells that have lost the typical
elongated fibrocyte morphology, taking on a more rounded appearance. Bar represents 50 mm. The serum-free culture conditions were changed to
serum-containing conditions after 4, 8, 11 and 14 days as indicated by the dotted line (B), with a reciprocal experiment where serum-containing
medium was changed to serum-free culture conditions (C). Data are the mean 6 sd of triplicate culture wells and are representative of three separate
experiments. The median number of cells with fibrocyte morphology at 24 h after the change of culture conditions from multiple experiments is
shown (D). ***=p,0.001; NS=not significant, p.0.05; Mann-Whitney test. Error bars are only shown in one direction for clarity.
doi:10.1371/journal.pone.0009730.g003
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PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9730Figure 4. Fibrocytes generated in serum-free and serum-containing conditions show distinct transcriptional profiles from each
other, as well as other monocyte-derived progeny. The expression of 35,788 genes was determined by gene microarray analysis for fibroblasts,
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used between passage 3 and 6. Time lapse photography of
fibrocyte cultures was carried out using a Zeiss Axiovert 200 and
Simple PCI version 5.0 computer software, with a frame every
5m i n f o r a t l e a s t 6h . T h e s t a g e o f t h e m i c r o s c o p e w a s a
humidified chamber at 37uCw i t h5 %C O 2.
serum-free (SF) and serum-containing (SC) fibrocytes, monocytes, macrophages, osteoclasts, immature and matured dendritic cells (DC). Data were
analysed using significance analysis of microarrays (SAM) for a comparison of all cell populations (A), following removal of the fibroblasts (B), a 3-way
analysis of the two fibrocyte populations and macrophages (C) as well as a paired comparison of just the two types of fibrocyte (D). Data are
represented as principal component analyses. The SAM gene list was used to perform a hierarchical cluster for both the samples and genes, with each
gene cluster labelled (E). The heat map scale represents the gene value relative to a standard reference sample expressed as the log2 ratio of
reference/sample; therefore green represents higher and red lower relative expression for each sample.
doi:10.1371/journal.pone.0009730.g004
Table 1. Pathways identified by DAVID analysis of the two-way SAM gene list of serum-free versus serum-containing fibrocytes.
Cluster Pathway Term Fold Enrichment
a Benjamini
C GO:0006334,nucleosome assembly 8.22 8.73E-03
C GO:0031497,chromatin assembly 7.89 6.59E-03
D GO:0002376,immune system process 2.57 2.40E-05
D GO:0006955,immune response 2.69 9.84E-05
D GO:0006952,defense response 3.57 1.43E-05
D GO:0006954,inflammatory response 3.98 1.74E-03
D GO:0009605,response to external stimulus 2.89 1.00E-03
D GO:0009611,response to wounding 3.55 5.91E-04
D GO:0042221,response to chemical stimulus 2.63 7.46E-03
D GO:0006935,chemotaxis 5.36 4.16E-03
D GO:0007626,locomotory behaviour 4.7 3.41E-03
D GO:0042330,taxis 5.36 4.16E-03
D GO:0006928,cell motility 3.16 4.30E-03
D GO:0051674,localization of cell 3.16 4.30E-03
D GO:0006665,sphingolipid metabolic process 8.72 6.32E-03
D GO:0030149,sphingolipid catabolic process 25.57 6.11E-03
D GO:0006629,lipid metabolic process 2.52 3.86E-03
D GO:0046466,membrane lipid catabolic process 19 3.95E-03
D GO:0007033,vacuole organization and biogenesis 19 3.95E-03
D GO:0006873,cellular ion homeostasis 4.66 2.04E-03
D GO:0030003,cellular cation homeostasis 4.78 4.57E-03
D GO:0048878,chemical homeostasis 4.59 2.30E-04
D GO:0050801,ion homeostasis 4.23 3.83E-03
D GO:0055080,cation homeostasis 4.75 4.61E-03
D GO:0055082,cellular chemical homeostasis 4.66 2.04E-03
D GO:0065008,regulation of biological quality 2.49 1.93E-03
E GO:0006464,protein modification process 2.02 1.34E-07
E GO:0006512,ubiquitin cycle 2.93 7.43E-06
E GO:0043687,post-translational protein modification 2.08 4.00E-07
E GO:0008104,protein localization 2.35 5.60E-05
E GO:0015031,protein transport 2.55 1.39E-05
E GO:0033036,macromolecule localization 2.21 2.95E-04
E GO:0045184,establishment of protein localization 2.44 3.02E-05
J GO:0015031,protein transport 3.09 8.70E-03
O GO:0006396,RNA processing 5.09 1.23E-06
O GO:0006397,mRNA processing 5.83 1.47E-04
O GO:0008380,RNA splicing 7.57 1.05E-06
O GO:0016071,mRNA metabolic process 5.54 4.45E-05
aThe pathways are listed where there was a greater than 2-fold enrichment and a Benjamini-corrected p,0.01, and are grouped according to the gene cluster and
biological function.
doi:10.1371/journal.pone.0009730.t001
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osteoclasts
In addition to fibrocytes, other monocyte-derived progeny were
generated from CD14
+ monocytes, with additional macrophages
generated from PBMC. For macrophage generation, cells were
cultured at 10
6/ml in Iscove’s modified Dulbecco’s medium
(IMDM; Sigma-Aldrich), 1% GPS, 10% pooled human AB
+ male
serum (Biosera) and 50 ng/ml M-CSF (Peprotech EC Ltd.,
London, UK). Dendritic cells (DC) were generated from
2.5610
6 CD14
+ monocytes resuspended in 5 ml RPMI 1640,
10% pooled human AB
+ male serum with recombinant human IL-
4 (500 U/ml) and GM-CSF (1000 U/ml; Immunotools, Frie-
soythe, Germany) and cultured for 6 days in T25 flasks (Sarstedt,
Leicester, UK). At day 3, 2 ml medium was removed and 2.5 ml
fresh medium added. At day 6 immature DC (iDC) were harvested
by shaking the flask vigorously and collecting non-adherent cells.
To produce mature DC (mDC), harvested iDC were cultured for 2
days with IL-1b (1 mg/ml; Peprotech, London, UK), IL-6
(200 ng/ml; Immunotools), TNFa (10 ng/ml; Peprotech) and
PGE2 (1 mg/ml; Sigma-Aldrich). Osteoclasts were generated from
PBMC by overnight culture in a minimal essential medium
(Lonza, Basel, Switzerland), 1% GPS with 10% HI-FCS, followed
by removal of non-adherent cells and culture in aMEM, 1%GPS,
10% HI-FCS, with M-CSF (30 ng/ml; Peprotech) and RANKL
(25 ng/ml; Peprotech) for 18 days. Medium was replaced with
fresh medium every 2 days.
Confocal immunofluorescence microscopy
Fibrocyte, macrophage and fibroblast cultures were established
in 8 well chamber slides and taken to day 11, day 7 and 60%
confluence, respectively. Medium was removed, the slides washed
three times in PBS for 5 min, air dried and fixed in acetone at
220uC for 15 min. Following rehydration with PBS/2% BSA for
5 min, slides were blocked for 20 min with 10% serum (same
species as the secondary antibody used). Following a PBS wash,
primary antibodies were added at previously determined optimal
concentrations and left overnight in a humidified chamber at 4uC.
Following two washes with PBS, secondary antibodies were added
and left for one hour. Following two PBS washes, nuclei were
counterstained with Hoechst (20 mg/ml; Bis-benzimid H33258
Fluorochrom, Sigma-Aldrich) and slides mounted in 2.4% 1,4-
Diazabicyclo[2.2.2]octane (Sigma-Aldrich) in glycerol, pH 8.6.
The slides were stored at 220uC until analysis using a Zeiss
Axiovert 100M confocal microscope and LSM 5.10 version 3.2
SP2 software. The specific primary antibodies used were rabbit
anti-human collagen I (1/100 dilution; Rockland; 600-401-103),
collagen III (1/25 dilution; Rockland; 600-401-105) and fibronec-
tin (1/100 dilution; Sigma-Aldrich; F3648), mouse anti-human
CD68 (1/25 dilution; BD Pharmingen, Oxford, UK; 556059),
CD3 (1/20 dilution; Dako, Ely, UK; M0835), CD13 (1/25
dilution; Immunotools; 21270131), CD45 (1/25 dilution; Immu-
notools; 21270451) and vimentin (1/100 dilution; Dako; M725)
with the isotype-matched irrelevant controls rabbit IgG, mouse
IgG2b and mouse IgG1 (1/5 dilution; Dako). The secondary
antibodies were Cy5 or Cy3 donkey anti-rabbit (1/125 dilution;
Jackson Immunoresearch Labs., West Grove, PA), Alexa Fluor
633 goat anti-mouse IgG1, -mouse IgG2b (1/100 dilution;
Invitrogen, Paisley, UK) and FITC goat anti-mouse IgG1 (1/
100 dilution; Southern Biotech, Birmingham, Alabama).
Transcriptome analysis
For transcriptome analysis SF fibrocytes were generated from
PBMC and SC from CD14
+ monocytes, to ensure sufficient
numbers from each donor. For each cell type generated triplicate
samples were differentiated from each of 3 different donors, with
all cell types, except fibroblasts, generated from each donor.
Cultures were harvested on days 11, 7, 8, 18 and 100% confluence
for fibrocytes, macrophages, iDC/mDC, osteoclasts and fibro-
blasts, respectively. Microarray slides were scanned using a
Scanarray GX+ scanner (Perkin-Elmer, Monza, Italy) and
analysed using Scanarray express version 3.03.0002 using variable
voltages. A prepared GAL file was used to annotate the slide
images and the intensity data was extracted and exported as gpr
files using the same software. These were uploaded into the Gene
Expression Pattern Analysis Suite (GEPAS) (Bioinformatics Unit
CNIO; http://gepas.bioinfo.cnio.es ) software for normalization,
which was performed using print-tip loess normalisation with half
background subtraction, initially within each slide and slide scale
normalisation subsequently between slides. Normalised data were
exported to TIGR Multi-experiment Viewer (TMEV), version 4.0
(http://www.tigr.org/tdb/euk ) and hierarchical clustering, sig-
nificance analysis of microarrays (SAM) and principle component
analysis (PCA) were performed. Cluster analysis was performed
using average linkage clustering on a Euclidean distance metric
matrix using the TMEV data analysis package. Microarray data
are available in the ArrayExpress database (www.ebi.ac.uk/
arrayexpress) under accession number E-MEXP-2434.
Online supplemental material
Figure S1 shows the morphology of fibrocytes, differentiated
from CD14
+ monocytes under SF conditions, following the
addition of serum. Figure S2 shows the length of fibrocytes,
generated under SF conditions, following the addition of serum.
Figure S3 shows the expression of vimentin, fibronectin and CD45
following the addition of serum to SF generated fibrocytes. Table
S1 is a list of genes identified by SAM (0.1% false discovery rate
(FDR)) when comparing monocytes, macrophages, osteoclasts,
iDC, mDC, SC fibrocytes, SF fibrocytes and fibroblasts. Table S2
is a list of genes identified by SAM (0.1% FDR) when comparing
monocytes, macrophages, osteoclasts, iDC, mDC, SC fibrocytes
and SF fibrocytes. Table S3 is a list of genes identified by SAM
(0.1% FDR) when comparing macrophages, SC fibrocytes and SF
fibrocytes. Table S4 is a list of genes identified by SAM (0.1%
FDR) when comparing SC fibrocytes and SF fibrocytes. Table S5
is a list of pathways identified by DAVID analysis of the paired
two-way SAM gene list of SF versus SC fibrocytes, where there
was a Benjamini-corrected p,0.01 or p,0.0001, and are grouped
according to the gene cluster.
Supporting Information
Figure S1 Addition of serum to serum-free CD14+-generated
fibrocytes results in a loss of fibrocyte morphology. Fibrocytes
generated from CD14+ monocytes under serum-free (SF) culture
conditions were cultured in the presence of serum-containing (SC)
culture medium. The serum-free culture conditions were changed
to serum-containing conditions after 4, 8, 11 and 14 days as
indicated by the dotted line, with a reciprocal experiment where
serum-containing medium was changed to serum-free culture
conditions. Data are the mean 6 sd of triplicate culture wells, and
are representative of 3 separate experiments. Error bars are only
shown in one direction for clarity.
Found at: doi:10.1371/journal.pone.0009730.s001 (0.16 MB TIF)
Figure S2 Decrease in serum-free generated fibrocyte length
following addition of serum. A - fibrocytes were generated under
serum free culture conditions and the mean length 6 sd of 5
fibrocytes is shown calculated from a time-course video of the cells.
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PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9730Fibrocytes were left untreated, or were transferred to medium
containing fetal calf serum (FCS) or human serum (HS), with heat-
inactivation as indicated (HI). B - the number of cells with
fibrocyte morphology is shown (mean 6 sd of triplicate culture
wells) over a number of days following a change of the culture
medium as indicated; serum-free (SF), serum-containing (SC).
Error bars are only shown in one direction for clarity.
Found at: doi:10.1371/journal.pone.0009730.s002 (0.14 MB TIF)
Figure S3 Serum-free fibrocytes retain expression of stromal and
haematopoietic cell markers in the presence of serum. Fibrocytes
were generated from PBMC under serum-free (SF) culture
conditions and transferred to serum-containing conditions for 24
h before immunostaining for vimentin, fibronectin and CD45. Bar
represents 50 mm. Data are representative of two separate
experiments. The brightness and contrast of these images have
been increased (20% and 25%, respectively).
Found at: doi:10.1371/journal.pone.0009730.s003 (0.55 MB TIF)
Table S1 Genes identified by SAM (0.1% FDR) when
comparing monocytes, macrophages, osteoclasts, iDC, mDC, SC
fibrocytes, SF fibrocytes and fibroblasts.
Found at: doi:10.1371/journal.pone.0009730.s004 (34.05 MB
XLS)
Table S2 Genes identified by SAM (0.1% FDR) when
comparing monocytes, macrophages, osteoclasts, iDC, mDC, SC
fibrocytes and SF fibrocytes.
Found at: doi:10.1371/journal.pone.0009730.s005 (26.50 MB
DOC)
Table S3 Genes identified by SAM (0.1% FDR) when
comparing macrophages, SC fibrocytes and SF fibrocytes.
Found at: doi:10.1371/journal.pone.0009730.s006 (2.06 MB
XLS)
Table S4 Genes identified by SAM (0.1% FDR) when
comparing SC fibrocytes and SF fibrocytes.
Found at: doi:10.1371/journal.pone.0009730.s007 (2.07 MB
XLS)
Table S5 Pathways identified by DAVID analysis of the paired
two-way SAM gene list of serum-free versus serum-containing
fibrocytes. The pathways are listed for all pathways and those
where there was a Benjamini-corrected p,0.01 or p,0.0001, and
are grouped according to the gene cluster.
Found at: doi:10.1371/journal.pone.0009730.s008 (0.07 MB
XLS)
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